Alternative names (23)
clinical trial • clinical trial phase • clinicalTest • clinicalTestAvailable • clinicalTesting • clinicalTrial • clinicalTrialIdentifier • clinicalTrialIndication • clinicalTrialLocation • clinicalTrialName • clinicalTrialPhase3 • clinicalTrialStatus • clinicalTrialTarget • clinicalTrials • clinicalTrialsGovID • clinicalTrialsPhase • countryOfClinicalTrial • has clinical trial phase • hasClinicalTrial • hasClinicalTrialPhase • hasClinicalTrials • notableClinicalTrial • trialDesign • moreRandom triples
| Subject | Object |
|---|---|
| gptkb:JNJ-2113 | Phase 3 |
| gptkb:Nerve_Growth_Factor_(NGF) | studied for Alzheimer's disease |
| gptkb:G6PDH | G6PD test |
| gptkb:CACNA1A | yes |
| gptkb:SAPIEN_valve | gptkb:PARTNER_trial |
| gptkb:YBB-202 | Phase 1 |
| gptkb:durvalumab | Phase III |
| gptkb:SCN1A_gene | Genetic testing for epilepsy |
| gptkb:molnupiravir | Phase 3 |
| gptkb:simufilam | Phase 3 (as of 2024) |
| gptkb:DMD_gene | muscle biopsy |
| gptkb:CYP21A2 | yes |
| gptkb:BGJ398 | Phase 2 |
| gptkb:Ad5-nCoV | NCT04526990 |
| gptkb:dovitinib | Phase III |
| gptkb:NT-0167 | Phase 1 |
| gptkb:Arexvy | Phase 3 |
| gptkb:CAR-T_cell | gptkb:Phase_I |
| gptkb:Skycovione | Phase 3 |
| gptkb:buparlisib | Phase III (as of 2023) |